136 related articles for article (PubMed ID: 25456112)
1. Prognostic value of biomarkers in metastatic colorectal cancer patients.
Kataoka K; Kanazawa A; Nakajima A; Yamaguchi A; Arimoto A
J Surg Res; 2015 Apr; 194(2):343-350. PubMed ID: 25456112
[TBL] [Abstract][Full Text] [Related]
2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
3. Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up.
Lassmann S; Hennig M; Rosenberg R; Nährig J; Schreglmann J; Krause F; Poignee-Heger M; Nekarda H; Höfler H; Werner M
Int J Colorectal Dis; 2006 Apr; 21(3):238-47. PubMed ID: 16132996
[TBL] [Abstract][Full Text] [Related]
4. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.
Meropol NJ; Gold PJ; Diasio RB; Andria M; Dhami M; Godfrey T; Kovatich AJ; Lund KA; Mitchell E; Schwarting R
J Clin Oncol; 2006 Sep; 24(25):4069-77. PubMed ID: 16943524
[TBL] [Abstract][Full Text] [Related]
5. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
6. Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer.
Hotta T; Kobayashi Y; Taniguchi K; Johata K; Sahara M; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
Oncol Rep; 2004 Aug; 12(2):347-51. PubMed ID: 15254700
[TBL] [Abstract][Full Text] [Related]
7. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
[TBL] [Abstract][Full Text] [Related]
8. 5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis.
Kuramochi H; Hayashi K; Uchida K; Miyakura S; Shimizu D; Vallbohmer D; Park S; Danenberg KD; Takasaki K; Danenberg PV
Int J Cancer; 2006 Aug; 119(3):522-6. PubMed ID: 16572420
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T
Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805
[TBL] [Abstract][Full Text] [Related]
10. Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases.
Maithel SK; Gönen M; Ito H; Dematteo RP; Allen PJ; Fong Y; Blumgart LH; Jarnagin WR; D'Angelica MI
Surgery; 2012 Feb; 151(2):162-70. PubMed ID: 21982065
[TBL] [Abstract][Full Text] [Related]
11. Molecular factors of 5-fluorouracil metabolism in colorectal cancer: analysis of primary tumor and lymph node metastasis.
Vallböhmer D; Kuramochi H; Shimizu D; Danenberg KD; Lindebjerg J; Nielsen JN; Jakobsen A; Danenberg PV
Int J Oncol; 2006 Feb; 28(2):527-33. PubMed ID: 16391809
[TBL] [Abstract][Full Text] [Related]
12. [Prediction of treatment outcome after adjuvant loco-regional chemotherapy following liver resection for colorectal metastases--preliminary results].
Strnad R; Ryska M; Belina F; Langer D; Novotný J; Ludvíková M
Rozhl Chir; 2006 Mar; 85(3):124-8. PubMed ID: 16689143
[TBL] [Abstract][Full Text] [Related]
13. Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis.
Ikeguchi M; Makino M; Kaibara N
Langenbecks Arch Surg; 2002 Oct; 387(5-6):240-5. PubMed ID: 12410361
[TBL] [Abstract][Full Text] [Related]
14. [The Relationship between the efficacy of mFOLFOX6 treatment and the expression of TS, DPD, TP, and ERCC-1 in unresectable colorectal cancer].
Kuwabara K; Kumamoto K; Ishibashi K; Okada N; Ishiguro T; Ohsawa T; Haga N; Miura I; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2224-7. PubMed ID: 22202337
[TBL] [Abstract][Full Text] [Related]
15. [Thymidylate synthase and dihydropyrimidine dehydrogenase gene expressions in colorectal cancer using the Danenberg tumor profile method].
Nagano H; Ichikawa W; Simizu M; Shirota Y; Nihei Z
Gan To Kagaku Ryoho; 2004 Jun; 31(6):889-92. PubMed ID: 15222106
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer.
Corsi DC; Ciaparrone M; Zannoni G; Mancini M; Cassano A; Specchia M; Pozzo C; Martini M; Barone C
Eur J Cancer; 2002 Mar; 38(4):527-34. PubMed ID: 11872345
[TBL] [Abstract][Full Text] [Related]
17. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis.
Inokuchi M; Uetake H; Shirota Y; Yamada H; Tajima M; Sugihara K
Cancer Chemother Pharmacol; 2004 May; 53(5):391-6. PubMed ID: 15060742
[TBL] [Abstract][Full Text] [Related]
18. 5-Fluorouracil-related gene expression in primary sites and hepatic metastases of colorectal carcinomas.
Sameshima S; Tomozawa S; Kojima M; Koketsu S; Motegi K; Horikoshi H; Okada T; Kon Y; Sawada T
Anticancer Res; 2008; 28(3A):1477-81. PubMed ID: 18630501
[TBL] [Abstract][Full Text] [Related]
19. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic and Predictive Value of Dihydropyrimidine Dehydrogenase-Related Indicators in Clinical Outcomes of Chemotherapy in Colorectal Cancer Patients: a Systematic Review and Meta-Analysis.
Sun X; Guo S
Pathol Oncol Res; 2020 Jan; 26(1):121-131. PubMed ID: 30519982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
